Controversies in the endovascular management of cerebral vasospasm after intracranial aneurysm rupture and future directions for therapeutic approaches

Neurosurgery

Volumn 62, Issue 4, 2008, Pages 897-905

  Komotar, Ricardo J ^a   Zacharia, Brad E ^a   Otten, Marc L ^a   Mocco, J ^a   Lavine, Sean D ^a,b  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b NEUROLOGICAL INSTITUTE   (United States)

Author keywords

Aneurysm; Angioplasty; Endovascular; Subarachnoid hemorrhage; Vasospasm

Indexed keywords

DISUFENTON SODIUM; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METHYLPREDNISOLONE; NAFAMSTAT MESILATE; NICARAVEN; NICARDIPINE; NIMODIPINE; NITRIC OXIDE; NITRIC OXIDE DONOR; PAPAVERINE; TIRILAZAD; VERAPAMIL;

AORTA BALLOON; ARTERY STEAL SYNDROME; BRAIN ARTERY ANEURYSM RUPTURE; BRAIN BLOOD FLOW; BRAIN STEM INJURY; BRAIN VASOSPASM; CATHETER; CLINICAL TRIAL; COIL EMBOLIZATION; CONFERENCE PAPER; COUNTERPULSATION; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG MEGADOSE; DRUG WITHDRAWAL; HUMAN; HYPOTENSION; INTRACRANIAL PRESSURE; ISCHEMIA; KIDNEY DISEASE; LUNG EDEMA; MORTALITY; NEUROIMAGING; NEUROTOXICITY; NONHUMAN; OUTCOME ASSESSMENT; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; SIDE EFFECT; STROKE; SUBARACHNOID HEMORRHAGE; THERAPY EFFECT; TRANSITIONAL BLINDNESS; TREATMENT INDICATION; TREATMENT OUTCOME; UNCONSCIOUSNESS; ANEURYSM RUPTURE; CLINICAL PRACTICE; INTRACRANIAL ANEURYSM; REVIEW; RUPTURE;

ANEURYSM, RUPTURED; INTRACRANIAL ANEURYSM; PHYSICIAN'S PRACTICE PATTERNS; RUPTURE, SPONTANEOUS; VASOSPASM, INTRACRANIAL;

EID: 48949119531     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/01.neu.0000318175.05591.c3     Document Type: Conference Paper

References (103)

1. Adams HP Jr, Brott TG, Crowell RM, Furlan AJ, Gomez CR, Grotta J, Helgason CM, Marler JR, Woolson RF, Zivin JA, Feinberg W, Mayberg M: Guidelines for the management of patients with acute ischemic stroke. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 25:1901-1914, 1994.
2. Afshar JK, Pluta RM, Boock RJ, Thompson BG, Oldfield EH: Effect of intracarotid nitric oxide on primate cerebral vasospasm after subarachnoid hemorrhage. J Neurosurg 83:118-122, 1995.
3. Andaluz N, Tomsick TA, Tew JM Jr, van Loveren HR, Yeh HS, Zuccarello M: Indications for endovascular therapy for refractory vasospasm after aneurysmal subarachnoid hemorrhage: experience at the University of Cincinnati. Surg Neurol 58:131-138, 2002.
4. Andaluz N, Zuccarello M: Fenestration of the lamina terminalis as a valuable adjunct in aneurysm surgery. Neurosurgery 55:1050-1059, 2004.
5. Apostolides PJ, Greene KA, Zabramski JM, Fitzgerald JW, Spetzler RF: Intra-aortic balloon pump counterpulsation in the management of concomitant cerebral vasospasm and cardiac failure after subarachnoid hemorrhage: Technical case report. Neurosurgery 38:1056-1060, 1996.
6. Asano T: Oxyhemoglobin as the principal cause of cerebral vasospasm: A holistic view of its actions. Crit Rev Neurosurg 9:303-318, 1999.
7. Asano T, Takakura K, Sano K, Kikuchi H, Nagai H, Saito I, Tamura A, Ochiai C, Sasaki T: Effects of a hydroxyl radical scavenger on delayed ischemic neurological deficits following aneurysmal subarachnoid hemorrhage: Results of a multicenter, placebo-controlled double-blind trial. J Neurosurg 84:792-803, 1996.
8. Babbitt DG, Perry JM, Forman MB: Intracoronary verapamil for reversal of refractory coronary vasospasm during percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 12:1377-1381, 1988.
9. Badjatia N, Topcuoglu MA, Pryor JC, Rabinov JD, Ogilvy CS, Carter BS, Rordorf GA: Preliminary experience with intra-arterial nicardipine as a treatment for cerebral vasospasm. AJNR Am J Neuroradiol 25:819-826, 2004.
10. Barth M, Capelle HH, Weidauer S, Weiss C, Munch E, Thome C, Luecke T, Schmiedek P, Kasuya H, Vajkoczy P: Effect of nicardipine prolonged-release implants on cerebral vasospasm and clinical outcome after severe aneurysmal subarachnoid hemorrhage: A prospective, randomized, double-blind phase IIa study. Stroke 38:330-336, 2007.
11. Bavbek M, Polin R, Kwan AL, Arthur AS, Kassell NF, Lee KS: Monoclonal antibodies against ICAM-1 and CD18 attenuate cerebral vasospasm after experimental subarachnoid hemorrhage in rabbits. Stroke 29:1930-1936, 1998.
12. Beck J, Raabe A, Lanfermann H, Berkefeld J, De Rochemont Rdu M, Zanella F, Seifert V, Weidauer S: Effects of balloon angioplasty on perfusion-and diffusion-weighted magnetic resonance imaging results and outcome in patients with cerebral vasospasm. J Neurosurg 105:220-227, 2006.
13. Bejjani GK, Bank WO, Olan WJ, Sekhar LN: The efficacy and safety of angioplasty for cerebral vasospasm after subarachnoid hemorrhage. Neurosurgery 42:979-987, 1998.
14. Biondi A, Ricciardi GK, Puybasset L, Abdennour L, Longo M, Chiras J, Van Effenterre R: Intra-arterial nimodipine for the treatment of symptomatic cerebral vasospasm after aneurysmal subarachnoid hemorrhage: Preliminary results. AJNR Am J Neuroradiol 25:1067-1076, 2004.
15. Chan PD, Findlay JM, Vollrath B, Cook DA, Grace M, Chen MH, Ashforth RA: Pharmacological and morphological effects of in vitro transluminal balloon angioplasty on normal and vasospastic canine basilar arteries. J Neurosurg 83:522-530, 1995.
16. Chyatte D, Fode NC, Nichols DA, Sundt TM Jr: Preliminary report: Effects of high dose methylprednisolone on delayed cerebral ischemia in patients at high risk for vasospasm after aneurysmal subarachnoid hemorrhage. Neurosurgery 21:157-160, 1987.
17. Clatterbuck RE, Gailloud P, Ogata L, Gebremariam A, Dietsch GN, Murphy KJ, Tamargo RJ: Prevention of cerebral vasospasm by a humanized anti-CD11/CD18 monoclonal antibody administered after experimental subarachnoid hemorrhage in nonhuman primates. J Neurosurg 99:376-382, 2003.
18. Clatterbuck RE, Oshiro EM, Hoffman PA, Dietsch GN, Pardoll DM, Tamargo RJ: Inhibition of vasospasm with lymphocyte function-associated antigen-1 monoclonal antibody in a femoral artery model in rats. J Neurosurg 97:676-682, 2002.
19. Clouston JE, Numaguchi Y, Zoarski GH, Aldrich EF, Simard JM, Zitnay KM: Intraarterial papaverine infusion for cerebral vasospasm after subarachnoid hemorrhage. AJNR Am J Neuroradiol 16:27-38, 1995.
20. Coyne TJ, Montanera WJ, Macdonald RL, Wallace MC: Percutaneous transluminal angioplasty for cerebral vasospasm after subarachnoid hemorrhage. Can J Surg 37:391-396, 1994.
21. Cross DT 3rd, Moran CJ, Angtuaco EE, Milburn JM, Diringer MN, Dacey RG Jr: Intracranial pressure monitoring during intraarterial papaverine infusion for cerebral vasospasm. AJNR Am J Neuroradiol 19:1319-1323, 1998.
22. Dorsch NW: Therapeutic approaches to vasospasm in subarachnoid hemorrhage. Curr Opin Crit Care 8:128-133, 2002.
23. Egemen N, Turker RK, Sanlidilek U, Zorlutuna A, Bilgic S, Baskaya M, Unlu A, Caglar S, Spetzler RF, McCormick JM: The effect of intrathecal sodium nitroprusside on severe chronic vasospasm. Neurol Res 15:310-315, 1993.
24. Elliott JP, Newell DW, Lam DJ, Eskridge JM, Douville CM, Le Roux PD, Lewis DH, Mayberg MR, Grady MS, Winn HR: Comparison of balloon angioplasty and papaverine infusion for the treatment of vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg 88:277-284, 1998.
25. Eskridge JM, McAuliffe W, Song JK, Deliganis AV, Newell DW, Lewis DH, Mayberg MR, Winn HR: Balloon angioplasty for the treatment of vasospasm: Results of first 50 cases. Neurosurgery 42:510-517, 1998.
26. Feng L, Fitzsimmons BF, Young WL, Berman MF, Lin E, Aagaard BD, Duong H, Pile-Spellman J: Intraarterially administered verapamil as adjunct therapy for cerebral vasospasm: Safety and 2-year experience. AJNR Am J Neuroradiol 23:1284-1290, 2002.
27. Firlik AD, Kaufmann AM, Jungreis CA, Yonas H: Effect of transluminal angioplasty on cerebral blood flow in the management of symptomatic vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg 86:830-839, 1997.
28. Firlik KS, Kaufmann AM, Firlik AD, Jungreis CA, Yonas H: Intra-arterial papaverine for the treatment of cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Surg Neurol 51:66-74, 1999.
29. Foster ED, Olsson CA, Rutenburg AM, Berger RL: Mechanical circulatory assistance with intra-aortic balloon counterpulsation for major abdominal surgery. Ann Surg 183:73-76, 1976.
30. Fujii Y, Takahashi A, Yoshimoto T: Effect of balloon angioplasty on high grade symptomatic vasospasm after subarachnoid hemorrhage. Neurosurg Rev 18:7-13, 1995.
31. Gabikian P, Clatterbuck RE, Eberhart CG, Tyler BM, Tierney TS, Tamargo RJ: Prevention of experimental cerebral vasospasm by intracranial delivery of a nitric oxide donor from a controlled-release polymer: Toxicity and efficacy studies in rabbits and rats. Stroke 33:2681-2686, 2002.
32. Haley EC Jr, Kassell NF, Alves WM, Weir BKA, Hansen CA: Phase II trial of tirilazad in aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study. J Neurosurg 82:786-790, 1995.
33. Haley EC Jr, Kassell NF, Apperson-Hansen C, Maile MH, Alves WM: A randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: A cooperative study in North America. J Neurosurg 86:467-474, 1997.
34. Heros RC, Zervas NT, Lavyne MH, Pickren KS: Reversal of experimental cerebral vasospasm by intravenous nitroprusside therapy. Surg Neurol 6:227-229, 1976.
35. Higashida RT, Halbach VV, Dowd CF, Dormandy B, Bell J, Hieshima GB: Intravascular balloon dilatation therapy for intracranial arterial vasospasm: Patient selection, technique, and clinical results. Neurosurg Rev 15:89-95, 1992.
36. Hillman J, Fridriksson S, Nilsson O, Yu Z, Säveland H, Jakobsson KE: Immediate administration of tranexamic acid and reduced incidence of early rebleeding after aneurysmal subarachnoid hemorrhage: A prospective randomized study. J Neurosurg 97:771-778, 2002.
37. Hirsh LF: Intra-arterial nitroprusside treatment of acute experimental vasospasm. Stroke 11:601-605, 1980.
38. Ito Y, Isotani E, Mizuno Y, Azuma H, Hirakawa K: Effective improvement of the cerebral vasospasm after subarachnoid hemorrhage with low-dose nitro-glycerin. J Cardiovasc Pharmacol 35:45-50, 2000.
39. Kaku Y, Yonekawa Y, Tsukahara T, Kazekawa K: Superselective intra-arterial infusion of papaverine for the treatment of cerebral vasospasm after sub-arachnoid hemorrhage. J Neurosurg 77:842-847, 1992.
40. Kassell NF, Helm G, Simmons N, Phillips CD, Cail WS: Treatment of cerebral vasospasm with intra-arterial papaverine. J Neurosurg 77:848-852, 1992.
41. Kassell NF, Torner JC, Jane JA, Haley EC Jr, Adams HP: The International Cooperative Study on the Timing of Aneurysm Surgery. Part 2: Surgical results. J Neurosurg 73:37-47, 1990.
42. Katoh H, Shima K, Shimizu A, Takiguchi H, Miyazawa T, Umezawa H, Nawashiro H, Ishihara S, Kaji T, Makita K, Tsuchiya K: Clinical evaluation of the effect of percutaneous transluminal angioplasty and intra-arterial papaverine infusion for the treatment of vasospasm following aneurysmal subarachnoid hemorrhage. Neurol Res 21:195-203, 1999.
43. Kawamoto S, Tsutsumi K, Yoshikawa G, Shinozaki MH, Yako K, Nagata K, Ueki K: Effectiveness of the head-shaking method combined with cisternal irrigation with urokinase in preventing cerebral vasospasm after subarachnoid hemorrhage. J Neurosurg 100:236-243, 2004.
44. Kinoshita Y, Terada T, Nakamura Y, Nakai E, Nakai K, Itakura T, Naka Y, Naka D, Takehara R, Imai H: Endovascular treatment of cerebral vasospasm with intra-arterial papaverine infusion [in Japanese]. No Shinkei Geka 23:881-887, 1995.
45. Kistler JP, Lees RS, Candia G, Zervas NT, Crowell RM, Ojemann RG: Intravenous nitroglycerin in experimental cerebral vasospasm. A preliminary report. Stroke 10:26-29, 1979.
46. Klebanoff LM, Fink ME, Lennihan L, Solomon RA, Mayer S, Beckford AR, Prohovnik I: Management of cerebral vasospasm in the 1990s. Clin Neuropharmacol 18:127-137, 1995.
47. Klimo P Jr, Kestle JR, MacDonald JD, Schmidt RH: Marked reduction of cerebral vasospasm with lumbar drainage of cerebrospinal fluid after sub-arachnoid hemorrhage. J Neurosurg 100:215-224, 2004.
48. Kobayashi H, Ide H, Aradachi H, Arai Y, Handa Y, Kubota T: Histological studies of intracranial vessels in primates following transluminal angioplasty for vasospasm. J Neurosurg 78:481-486, 1993.
49. Komotar RJ, Olivi A, Rigamonti D, Tamargo RJ: Microsurgical fenestration of the lamina terminalis reduces the incidence of shunt-dependent hydrocephalus after aneurysmal subarachnoid hemorrhage. Neurosurgery 51:1403-1413, 2002.
50. Kwan AL, Bavbek M, Jeng AY, Maniara W, Toyoda T, Lappe RW, Kassell NF, Lee KS: Prevention and reversal of cerebral vasospasm by an endothelin- converting enzyme inhibitor, CGS 26303, in an experimental model of sub-arachnoid hemorrhage. J Neurosurg 87:281-286, 1997.
51. Laufs U, Fata VL, Liao JK: Inhibition of 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase blocks hypoxia-mediated down-regulation of endothelial nitric oxide synthase. J Biol Chem 272:31725-31729, 1997.
52. Lavine SD, Wang M, Etu JJ, Meyers PM, Joshi S: Augmentation of cerebral blood flow and reversal of endothelin-1-induced vasospasm: a comparison of intracarotid nicardipine and verapamil. Neurosurgery 60:742-749, 2007.
53. Lees KR, Barer D, Ford GA, Hacke W, Kostulas V, Sharma AK, Odergren T: Tolerability of NXY-059 at higher target concentrations in patients with acute stroke. Stroke 34:482-487, 2003.
54. Lees KR, Sharma AK, Barer D, Ford GA, Kostulas V, Cheng YF, Odergren T: Tolerability and pharmacokinetics of the nitron NXY-059 in patients with acute stroke. Stroke 32:675-680, 2001.
55. Mack WJ, Mocco J, Hoh DJ, Huang J, Choudhri TF, Kreiter KT, Lozier A, Opperman M, Poisik A, Yorgason J, Solomon RA, Mayer SA, Connolly ES: Outcome prediction with serum intercellular adhesion molecule-1 levels after aneurysmal subarachnoid hemorrhage. J Neurosurg 96:71-75, 2002.
56. Manno EM, Gress DR, Ogilvy CS, Stone CM, Zervas NT: The safety and efficacy of cyclosporine A in the prevention of vasospasm in patients with Fisher grade 3 subarachnoid hemorrhages: A pilot study. Neurosurgery 40:289-293, 1997.
57. Marshall JW, Cummings RM, Bowes LJ, Ridley RM, Green AR: Functional and histological evidence for the protective effect of NXY-059 in a primate model of stroke when given 4 hours after occlusion. Stroke 34:2228-2233, 2003.
58. Marshall JW, Duffin KJ, Green AR, Ridley RM: NXY-059, a free radical-trapping agent, substantially lessens the functional disability resulting from cerebral ischemia in a primate species. Stroke 32:190-198, 2001.
59. Marshall JW, Green AR, Ridley RM: Comparison of the neuroprotective effect of clomethiazole, AR-R15896AR and NXY-059 in a primate model of stroke using histological and behavioural measures. Brain Res 972:119-126, 2003.
60. Marshall JW, Ridley RM: Assessment of cognitive and motor deficits in a marmoset model of stroke. ILAR J 44:153-160, 2003.
61. Mayberg MR: Cerebral vasospasm. Neurosurg Clin N Am 9:615-627, 1998.
62. McAuliffe W, Townsend M, Eskridge JM, Newell DW, Grady MS, Winn HR: Intracranial pressure changes induced during papaverine infusion for treatment of vasospasm. J Neurosurg 83:430-434, 1995.
63. Megyesi JF, Vollrath B, Cook DA, Chen MH, Findlay JM: Long-term effects of in vivo angioplasty in normal and vasospastic canine carotid arteries: Pharmacological and morphological analyses. J Neurosurg 91:100-108, 1999.
64. Milburn JM, Moran CJ, Cross DT 3rd, Diringer MN, Pilgram TK, Dacey RG Jr: Increase in diameters of vasospastic intracranial arteries by intraarterial papaverine administration. J Neurosurg 88:38-42, 1998.
65. Mocco J, Choudhri TF, Mack WJ, Laufer I, Lee J, Kiss S, Poisik A, Quest DO, Solomon RA, Connolly ES: Elevation of soluble intercellular adhesion molecule-1 levels in symptomatic and asymptomatic carotid atherosclerosis. Neurosurgery 48:718-722, 2001.
66. Mocco J, Mack WJ, Kim GH, Lozier AP, Laufer I, Kreiter KT, Sciacca RR, Solomon RA, Mayer SA, Connolly ES Jr: Rise in serum soluble intercellular adhesion molecule-1 levels with vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg 97:537-541, 2002.
67. Muizelaar JP: Balloon prophylaxis of aneurysmal vasospasm. Presented at the International Stroke Conference, San Francisco, CA, February 2007.
68. Muizelaar JP, Zwienenberg M, Rudisill NA, Hecht ST: The prophylactic use of transluminal balloon angioplasty in patients with Fisher Grade 3 sub-arachnoid hemorrhage: A pilot study. J Neurosurg 91:51-58, 1999.
69. Mullan S, Dawley J: Antifibrinolytic therapy for intracranial aneurysms. J Neurosurg 28:21-23, 1968.
70. Murayama Y, Song JK, Uda K, Gobin YP, Duckwiler GR, Tateshima S, Patel AB, Martin NA, Viñuela F: Combined endovascular treatment for both intracranial aneurysm and symptomatic vasospasm. AJNR Am J Neuroradiol 24:133-139, 2003.
71. Newell DW, Eskridge JM, Mayberg MR, Grady MS, Winn HR: Angioplasty for the treatment of symptomatic vasospasm following subarachnoid hemorrhage. J Neurosurg 71:654-660, 1989.
72. Nilsson OG, Brandt L, Ungerstedt U, Säveland H: Bedside detection of brain ischemia using intracerebral microdialysis: Subarachnoid hemorrhage and delayed ischemic deterioration. Neurosurgery 45:1176-1185, 1999.
73. Nirei H, Hamada K, Shoubo M, Sogabe K, Notsu Y, Ono T: An endothelin ETA receptor antagonist, FR139317, ameliorates cerebral vasospasm in dogs. Life Sci 52:1869-1874, 1993.
74. Numaguchi Y, Zoarski GH: Intra-arterial papaverine treatment for cerebral vasospasm: Our experience and review of the literature. Neurol Med Chir (Tokyo) 38:189-195, 1998.
75. Nussbaum ES, Heros RC, Solien EE, Madison MT, Sebring LA, Latchaw RE: Intra-aortic balloon counterpulsation augments cerebral blood flow in a canine model of subarachnoid hemorrhage-induced cerebral vasospasm. Neurosurgery 36:879-886, 1995.
76. Nussbaum ES, Sebring LA, Ganz WF, Madison MT: Intra-aortic balloon counterpulsation augments cerebral blood flow in the patient with cerebral vasospasm: A xenon-enhanced computed tomography study. Neurosurgery 42:206-214, 1998.
77. O'Driscoll G, Green D, Taylor RR: Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month. Circulation 95:1126-1131, 1997.
78. Oshiro EM, Hoffman PA, Dietsch GN, Watts MC, Pardoll DM, Tamargo RJ: Inhibition of experimental vasospasm with anti-intercellular adhesion molecule-1 monoclonal antibody in rats. Stroke 28:2031-2038, 1997.
79. Parra A, Kreiter KT, Williams S, Sciacca R, Mack WJ, Naidech AM, Commichau CS, Fitzsimmons BF, Janjua N, Mayer SA, Connolly ES Jr: Effect of prior statin use on functional outcome and delayed vasospasm after acute aneurysmal subarachnoid hemorrhage: A matched controlled cohort study. Neurosurgery 56:476-484, 2005.
80. Paulson OB: Regional cerebral blood flow in apoplexy due to occlusion of the middle cerebral artery. Neurology 20:63-77, 1970.
81. Pluta RM, Oldfield EH, Boock RJ: Reversal and prevention of cerebral vasospasm by intracarotid infusions of nitric oxide donors in a primate model of subarachnoid hemorrhage. J Neurosurg 87:746-751, 1997.
82. Polin RS, Hansen CA, German P, Chadduck JB, Kassell NF: Intra-arterially administered papaverine for the treatment of symptomatic cerebral vasospasm. Neurosurgery 42:1256-1267, 1998.
83. Pomerantz RM, Kuntz RE, Diver DJ, Safian RD, Baim DS: Intracoronary verapamil for the treatment of distal microvascular coronary artery spasm following PTCA. Cathet Cardiovasc Diagn 24:283-285, 1991.
84. Pradilla G, Wang PP, Legnani FG, Ogata L, Dietsch GN, Tamargo RJ: Prevention of vasospasm by anti-CD11/CD18 monoclonal antibody therapy following subarachnoid hemorrhage in rabbits. J Neurosurg 101:88-92, 2004.
85. Rosenwasser RH, Armonda RA, Thomas JE, Benitez RP, Gannon PM, Harrop J: Therapeutic modalities for the management of cerebral vasospasm: Timing of endovascular options. Neurosurgery 44:975-980, 1999.
86. Roux S, Breu V, Giller T, Neidhart W, Ramuz H, Coassolo P, Clozel J P, Clozel M: Ro 61-1790, a new hydrosoluble endothelin antagonist: General pharmacology and effects on experimental cerebral vasospasm. J Pharmacol Exp Ther 283:1110-1118, 1997.
87. Säveland H, Nilsson OG, Boris-Moller F, Wieloch T, Brandt L: Intracerebral microdialysis of glutamate and aspartate in two vascular territories after aneurysmal subarachnoid hemorrhage. Neurosurgery 38:12-20, 1996.
88. Sercombe R, Dinh YR, Gomis P: Cerebrovascular inflammation following subarachnoid hemorrhage. Jpn J Pharmacol 88:227-249, 2002.
89. Smith T P, Enterline DS: Endovascular treatment of cerebral vasospasm. J Vasc Interv Radiol 11:547-559, 2000.
90. Smith WS, Dowd CF, Johnston SC, Ko NU, DeArmond SJ, Dillon WP, Setty D, Lawton MT, Young WL, Higashida RT, Halbach VV: Neurotoxicity of intra-arterial papaverine preserved with chlorobutanol used for the treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Stroke 35:2518-2522, 2004.
91. Song JK, Elliott J P, Eskridge JM: Neuroradiologic diagnosis and treatment of vasospasm. Neuroimaging Clin N Am 7:819-835, 1997.
92. Suzuki I SH, Takahasi H: Head shaking method in cisternal irrigation for prevention of vasospasm. Surg Cereb Stroke 19:295-300, 1991.
93. Sviri GE, Britz GW, Lewis DH, Newell DW, Zaaroor M, Cohen W: Dynamic perfusion computed tomography in the diagnosis of cerebral vasospasm. Neurosurgery 59:319-325, 2006.
94. Taniyama Y, Ito H, Iwakura K, Masuyama T, Hori M, Takiuchi S, Nishikawa N, Higashino Y, Fujii K, Minamino T: Beneficial effect of intracoronary verapamil on microvascular and myocardial salvage in patients with acute myocardial infarction. J Am Coll Cardiol 30:1193-1199, 1997.
95. Thomas JE, Nemirovsky A, Zelman V, Giannotta SL: Rapid reversal of endothelin-1-induced cerebral vasoconstriction by intrathecal administration of nitric oxide donors. Neurosurgery 40:1245-1249, 1997.
96. Thomas JE, Rosenwasser RH: Reversal of severe cerebral vasospasm in three patients after aneurysmal subarachnoid hemorrhage: initial observations regarding the use of intraventricular sodium nitroprusside in humans. Neurosurgery 44:48-58, 1999.
97. Thomas JE, Rosenwasser RH, Armonda RA, Harrop J, Mitchell W, Galaria I: Safety of intrathecal sodium nitroprusside for the treatment and prevention of refractory cerebral vasospasm and ischemia in humans. Stroke 30:1409-1416, 1999.
98. Tierney TS, Clatterbuck RE, Lawson C, Thai QA, Rhines LD, Tamargo RJ: Prevention and reversal of experimental posthemorrhagic vasospasm by the periadventitial administration of nitric oxide from a controlled-release polymer. Neurosurgery 49:945-953, 2001.
99. Tranmer BI, Peniston C, Iacobacci R, Salerno TA, Hudson AR: Intra-aortic balloon counterpulsation: A treatment for ischaemic stroke? Neurol Res 11:109-113, 1989.
100. Vajkoczy P, Horn P, Bauhuf C, Munch E, Hubner U, Ing D, Thome C, Poeckler-Schoeninger C, Roth H, Schmiedek P: Effect of intra-arterial papaverine on regional cerebral blood flow in hemodynamically relevant cerebral vasospasm. Stroke 32:498-505, 2001.
101. Weidauer S, Lanfermann H, Raabe A, Zanella F, Seifert V, Beck J: Impairment of cerebral perfusion and infarct patterns attributable to vasospasm after aneurysmal subarachnoid hemorrhage: A prospective MRI and DSA study. Stroke 38:1831-1836, 2007.
102. Yanamoto H, Kikuchi H, Sato M, Shimizu Y, Yoneda S, Okamoto S: Therapeutic trial of cerebral vasospasm with the serine protease inhibitor, FUT-175, administered in the acute stage after subarachnoid hemorrhage. Neurosurgery 30:358-363, 1992.
103. Zubkov YN, Nikiforov BM, Shustin VA: Balloon catheter technique for dilatation of constricted cerebral arteries after aneurysmal SAH. Acta Neurochir (Wien) 70:65-79, 1984.